The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 133, No 6, 738-741.
© 2002 American Dental Association

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SURATTANONT, F.
Right arrow Articles by WOLINSKY, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SURATTANONT, F.
Right arrow Articles by WOLINSKY, B.
Related Collections
Right arrow Periodontics

CLINICAL PRACTICE

CASE REPORT

Bilateral parotid swelling caused by sarcoidosis



FARISA SURATTANONT, D.D.S., LOUIS MANDEL, D.D.S. and BARRY WOLINSKY, D.D.S., M.S.


   ABSTRACT
 TOP
 ABSTRACT
 CASE REPORT
 DISCUSSION
 CONCLUSION
 REFERENCES
 
Background. Sarcoidosis is a multi-system granulomatous disease characteristically causing bilateral hilar lymphadenopathy. Salivary gland swellings also are seen, which mandate recognition by the dental profession.

Case Description. The authors describe a patient whose diagnosis of sarcoidosis was tenuous. Ocular involvement and an elevated serum angiotensin-converting enzyme level suggested a diagnosis of sarcoidosis. Confirmation with a tissue biopsy was achieved only when the clinicians recognized that salivary gland swelling probably represented a manifestation of the disease. Steroid therapy was instituted.

Clinical Implications. It is important for the dental practitioner to be familiar with the salivary gland manifestation of sarcoidosis. Early recognition and intervention aborts or slows disease progression.

Sarcoidosis is a multisystem granulomatous disease of unknown etiology, most commonly affecting adults and, at times, children. The disease characteristically causes bilateral hilar lymphadenopathy and granulomatous pulmonary, skin or ocular lesions.1 When the disease develops in children, it occurs in two distinct forms.2,3 Early-onset sarcoidosis appears before the age of 4 years and is characterized by a triad of a rash, uveitis and arthritis, but no demonstrable pulmonary involvement. Late-onset sarcoidosis appears in older children, who often develop a multisystem disease and exhibit hilar lymphadenopathy and pulmonary infiltration. It is important for the dental community to be aware of this disease, because patients with the oral manifestations of sarcoidosis may be seen in the dental office.

The dental practitioner should be familiar with the salivary gland manifestation of sarcoidosis.

The prevalence and incidence in young children are unknown.4 Most cases develop in patients ranging in age from 8 to 15 years.5 Prevalence increases until adulthood, with the 20- to 40-year-old age group being most susceptible.6 Among children diagnosed with sarcoidosis, there is no established sex predilection. In adults, sarcoidosis tends to be more common in women.7 In addition, research has clearly established that in the United States, sarcoidosis affects African-Americans more commonly than it does whites, with a ratio varying from 10:1 to 17:1.2 Furthermore, more than 70 percent of the pediatric cases in the United States have been reported from the Southeastern and South Central regions, suggesting an endemic pattern for childhood sarcoidosis.3


   CASE REPORT
 TOP
 ABSTRACT
 CASE REPORT
 DISCUSSION
 CONCLUSION
 REFERENCES
 
A 13-year-old black girl was referred to Columbia University’s Salivary Gland Center, or SGC, New York, with a four-month history of a painless, symmetrical, bilateral, parotid swelling first noticed by her mother (Figure 1Go). The patient reported no history of any fluctuations in size, with or without eating.



View larger version (98K):
[in this window]
[in a new window]
 
Figure 1. Patient with sarcoidosis and bilateral parotid swelling (arrows).

 
A medical history indicated that the patient had been seen by her pediatrician about six weeks earlier. Because sarcoidosis was suspected, a serum angiotensin-converting enzyme, or ACE, test was performed. The results showed an elevated enzyme level, which is consistent with sarcoidosis. Chest radiographs failed to reveal any pulmonary involvement or a hilar lymphadenopathy. Because the patient complained of an eye inflammation, the pediatrician referred her to an ophthalmologist, who suspected uveitis and prescribed prednisone.

Because the chest radiographs were negative and because ACE is not a specific test for sarcoidosis, the ophthalmologist could not make a firm diagnosis of a sarcoidal uveitis. Therefore, the patient’s pediatrician referred her to the SGC for evaluation of the parotid swellings.

Extraoral palpation indicated that the parotid swellings were firm and painless. They followed the anatomic configuration of both parotid glands. The overlying skin was not inflamed. We found no trismus, and palpation detected no cervical lymphadenopathy.

Stimulated salivary volume. Intraorally, the mucosa appeared moist. We used a modified Carlsen-Crittenden collector to measure stimulated salivary volume from each parotid gland individually. A smaller-than-normal volume of saliva was obtained from each gland. The right parotid produced 0.4 milliliters per minute, while the left parotid produced 0.3 mL/minute (normal, 0.5 to 1.0 mL/minute). Furthermore, the saliva was quite viscous, indicating the presence of an inflammatory process. The salivary chemistry of both glands revealed significant elevations of electrolyte and protein levels, thus substantiating the existence of a bilateral parotid inflammation.

Salivary gland biopsy. To establish a diagnosis of sarcoidosis, we performed a labial salivary gland biopsy. Histologic examination of the specimen revealed numerous noncaseating granulomas infiltrating and replacing the glandular parenchyma, a pattern associated with sarcoidosis (Figure 2Go). Special staining ruled out the presence of mycobacterial or fungal infections, berylliosis and a foreign body, conditions that produce similar granulomas.



View larger version (146K):
[in this window]
[in a new window]
 
Figure 2. Photomicrograph of a labial salivary gland biopsy specimen shows granuloma peripherally delineated by lymphocytes (arrows) in a bed of normal labial salivary gland tissue (A). Giant cells are present (hematoxylin-eosin stain, original magnification x125).

 
The clinical picture of bilateral parotid gland swelling, uveitis and an elevated ACE level pointed to a diagnosis of sarcoidosis. Once this clinical diagnosis was substantiated by the histologic examination of labial salivary gland tissue, we referred the patient back to her pediatrician, who initiated a regimen of systemic steroid therapy with close monitoring.


   DISCUSSION
 TOP
 ABSTRACT
 CASE REPORT
 DISCUSSION
 CONCLUSION
 REFERENCES
 
Despite extensive studies, no agent has been identified as the cause of sarcoidosis. Several studies suggest that an infectious organism is the cause, particularly mycobacteria.810 Sarcoidosis currently is considered a chronic inflammatory disease, distinguished by hyperimmune reactions to an unspecified agent at the lesion sites. Continuous stimulation by the antigenic agent sustains the pathological process.11

The clinical presentation of sarcoidosis varies, because it is a multisystem disease and affects several organs.5 Organs most frequently involved include the lungs, lymph nodes, eyes, skin, liver, spleen and salivary glands. The organs may be symptomatic or silent in their presentation. In addition, most cases of childhood sarcoidosis are accompanied by nonspecific symptoms, including fever, weight loss, fatigue, cough or rashes.

Of great significance to the dental profession is the involvement of the salivary glands in this disease. Parotid gland swelling has been reported in 4 to 6 percent of patients diagnosed with sarcoidosis.12,13 Parotid enlargement is a more frequent finding in children diagnosed with early-onset sarcoidosis.14

Clinical patterns. The salivary gland involvement may manifest itself in a variety of clinical patterns. The most common pattern is represented by major salivary gland swelling, with histologic involvement of the minor salivary glands.15 Xerostomia may be present (a decreased salivary volume was observed in our patient), and it is directly proportional to the extent of the granulomatous infiltration into the gland. Spontaneous regression of the swelling can be expected.16

A second pattern of salivary gland involvement is characterized by the absence of clinical salivary gland swelling. Regardless of whether swelling is present, however, histologic examination of minor salivary gland biopsy specimens usually will reveal the presence of noncaseating granulomas. The palatine mucous gland will demonstrate granulomas in 38 percent of patients with known sarcoidosis, while labial salivary glands that have undergone a biopsy reveal granulomas in 58 percent of patients.17,18

A definitive diagnosis of sarcoidosis is best achieved by integrating clinical data with the presence of noncaseating granulomas.

A third manifestation of salivary involvement in sarcoidosis is uveoparotid fever, or Heerfordt’s syndrome, which consists of a triad of symptoms including bilateral parotid swelling, uveitis and cranial nerve involvement. This symptom complex rarely is seen in children.

It is important for dentists to be aware that the first clinical sign of sarcoidosis may be parotid or even submandibular salivary gland involvement, with parotid sialadenopathy a frequent finding in children.12,13 No specific laboratory tests exist for sarcoidosis. However, the ACE level typically is elevated in approximately 80 percent of children19,20 and 60 percent of adults with late-onset sarcoidosis.21 The ACE test has proven to be less sensitive in patients diagnosed with early-onset sarcoidosis.22

ACE normally is found in many organs and body fluids and is secreted by pulmonary capillary endothelial cells and alveolar macrophages, as well as by the epithelial cells of the renal proximal tubules.23 The elevated ACE level in patients with sarcoidosis results from its production by the epithelioid cells of the granuloma.3 Although ACE test results have been shown to aid in the diagnosis of sarcoidosis and in monitoring its course and activity, many other disorders are associated with elevated ACE levels, including miliary tuberculosis, leprosy and Gaucher’s disease.24 However, other investigative measures can be used to rule out these entities.

Diagnosing sarcoidosis. A definitive diagnosis of sarcoidosis is best achieved by integrating clinical data with the presence of noncaseating granulomas. Histologically, the granuloma is characterized by tightly grouped epithelioid cells interspersed with a small number of giant cells. Accumulations of lymphocytic cells may be seen at the periphery of the granuloma. To further support the diagnosis of sarcoidosis, clinicians must use special stains to rule out the aforementioned other granulomatous conditions (for example, histoplasmosis, blastomycosis, berylliosis, foreign bodies, tuberculosis, leprosy). Clinical data and negative culture results also contribute significantly to the diagnosis. Furthermore, the clinician should be aware that noncaseating granulomas occasionally are seen in cases of tuberculosis.25

Because parotid swelling is not an uncommon finding in children, it is important for the dentist to consider this disease when other, more common, causes of parotid swelling in children, such as mumps or recurrent juvenile parotitis, have been ruled out. Confirmation of a clinical diagnosis of sarcoidosis can be established on the cumulative basis of the patient’s medical history, clinical examination results, chest radiographic findings, elevated serum ACE levels and the results of a microscopic examination of a labial gland biopsy specimen with the use of special stains.

Corticosteroid therapy. After we discussed the parotid swellings with the patient’s pediatrician, she initiated a regimen of corticosteroids, which is the current therapy of choice for childhood sarcoidosis. Low-dose methotrexate therapy also can be instituted because methotrexate is an effective immunosuppressive agent and has steroid-sparing properties.3 The goal of therapy is to minimize or prevent inflammation and granuloma formation, which can lead to organ system dysfunction and ultimately cause end-stage organ destruction by the development of hyaline fibrosis. If the eye is involved, blindness might result. Therefore, the presence of an uveitis demands aggressive steroid therapy.

Few studies have been conducted to examine the prognosis of sarcoidosis in children because of the small number of cases reported. However, the cases that have been reported suggest that the prognosis is good for childhood sarcoidosis.26,27 Children diagnosed with sarcoidosis usually have a favorable outcome, with spontaneous regression. Although the condition of most children improves, a significant number experience major complications. A 3 percent mortality rate has been reported in one review.3 Patients who experience multisystem involvement often suffer from chronic disease. Early diagnosis and treatment can slow or stop the progression to organ destruction. Therein lies the need for prompt recognition of the entity by the dental practitioner.


   CONCLUSION
 TOP
 ABSTRACT
 CASE REPORT
 DISCUSSION
 CONCLUSION
 REFERENCES
 
We have reviewed the clinical symptoms of sarcoidosis, a benign, multisystem, granulomatous disease. The roles of ACE, salivary gland swelling and histologic examination results of a labial gland biopsy specimen in the diagnosis of sarcoidosis are highlighted. The case described above illustrates the salient features of this disease of unknown etiology.



View larger version (123K):
[in this window]
[in a new window]
 
Dr. Surattanont is a research assistant and a pediatric dental resident, New York-Presbyterian Hospital (Columbia Campus), New York.

 


View larger version (117K):
[in this window]
[in a new window]
 
Dr. Mandel is director, Salivary Gland Center, New York-Presbyterian Hospital (Columbia Campus), New York, and assistant dean and a clinical professor, Oral and Maxillofacial Surgery, Columbia University School of Dental and Oral Surgery, 630 W. 168th St., New York, N.Y. 10032. Address reprint requests to Dr. Mandel.

 


   FOOTNOTES
 

Dr. Wolinsky is an assistant clinical professor, Oral and Maxillofacial Surgery, Columbia University School of Dental and Oral Surgery, New York.


   REFERENCES
 TOP
 ABSTRACT
 CASE REPORT
 DISCUSSION
 CONCLUSION
 REFERENCES
 

  1. Yammamoto M, Sharma OP, Hosoda Y. The 1991 descriptive definition of sarcoidosis. Sarcoidosis 1993;9:33–4.[Medline]

  2. Pattishall EN, Strope GL, Spinola SM, Denny FW. Childhood sarcoidosis. J Pediatr 1986;108:169–77.[Medline]

  3. Shetty AK, Gedalia A. Sarcoidosis: a pediatric perspective. Clin Pediatr 1998;37:707–17.[Abstract/Free Full Text]

  4. Bresnitz EA, Strom BL. Epidemiology of sarcoidosis. Epidemiol Rev 1983;5:124–56.[Free Full Text]

  5. Kendig EL. Sarcoidosis in children: personal observations on age distribution. Pediatr Pulmonol 1989;6:69–70.[Medline]

  6. Izumi T. Symposium: population differences in clinical features and prognosis of sarcoidosis throughout the world. Sarcoidosis 1993; 9:105–18.

  7. Hosoya S, Kataoka M, Nakata Y, et al. Clinical features of 125 patients with sarcoidosis: Okayama University Hospital review of a recent 10-year period. Acta Med Okayama 1992;46:31–6.[Medline]

  8. Mitchell DN. Mycobacteria and sarcoidosis. Lancet 1996;348:768–9.[Medline]

  9. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992;339:1012–5.[Medline]

  10. Mitchell IC, Turke JL, Mitchell DN. Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation. Lancet 1992;339:1015–7.[Medline]

  11. DuBois RM, Kirby M, Balbi B, Saltini C, Crystal RG. T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor. Am Rev Respir Dis 1992;145:1205–11.[Medline]

  12. James D, Neville E, Siltzbach L, et al. A worldwide review of sarcoidosis. Ann N Y Acad Sci 1976;278:321–34.[Medline]

  13. Greenberg G, Anderson R, Sharpstone P, et al. Enlargement of the parotid gland due to sarcoidosis. Br Med J 1964;2:861–2.[Medline]

  14. Hafner R, Vogel P. Sarcoidosis of early onset: a challenge for the pediatric rheumatologist. Clin Exp Rheumatol 1993;11:685–91.[Medline]

  15. Mandel L, Kaynar A. Sialadenopathy: a clinical herald of sarcoidosis—report of two cases. J Oral Maxillofac Surg 1994;52:1208–10.[Medline]

  16. Som P, Shugar J, Biller H. Parotid gland sarcoidosis and the CT sialogram. J Comput Assist Tomogr 1981;5:674–7.[Medline]

  17. Cahn L, Eisenbud L, Blake M, Stern D. Biopsies of normal-appearing palates of patients with known sarcoidosis. Oral Surg Oral Med Oral Pathol 1964;18:342–5.[Medline]

  18. Nessan V, Jacoway J. Biopsy of minor salivary glands in the diagnosis of sarcoidosis. N Engl J Med 1979;301:922–4.[Medline]

  19. Rodriquez GE, Shin BC, Abernathy RS, Kendig EL. Serum angiotensin-converting enzyme activity in normal children and in those with sarcoidosis. J Pediatr 1981;99:68–72.[Medline]

  20. Beneteau-Burnat B, Baudin B, Morgant G, Baumann FC, Giboudeau J. Serum angiotensin-converting enzyme activity in healthy and sarcoidotic children: comparison with the reference interval for adults. Clin Chem 1990;36:344–6.[Abstract/Free Full Text]

  21. Steinberg MJ, Mueller DP. Treating oral sarcoidosis. JADA 1994; 125:76–9.[Medline]

  22. Hurwitz S. Clinical pediatric dermatology. 2nd ed. Philadelphia: Saunders; 1993:649–52.

  23. Ryan US, Clements E, Habliston D, Ryan JW. Isolation and culture of pulmonary artery endothelial cells. Tissue Cell 1978;10:535–54.[Medline]

  24. Gedalia A, Molina JF, Ellis GS, Galen W, Moore C, Espinoza LR. Low-dose methotrexate therapy for childhood sarcoidosis. J Pediatr 1997;130:25–9.[Medline]

  25. Cutler RR, Baithun SI, Doran HM, Wilson P. Association between the histological diagnosis of tuberculosis and microbiological findings. Tuber Lung Dis 1994;75:75–9.[Medline]

  26. Marcille R, McCarthy M, Barton JW, Merten DF, Spock A. Long-term outcome of pediatric sarcoidosis with emphasis on pulmonary status. Chest 1992;102:1444–9.[Abstract/Free Full Text]

  27. Sharma OP. Sarcoidosis. Dis Month 1990;36:469–535.





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SURATTANONT, F.
Right arrow Articles by WOLINSKY, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SURATTANONT, F.
Right arrow Articles by WOLINSKY, B.
Related Collections
Right arrow Periodontics


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS